About the Duchenne Drug Development Pipeline
This page shows investigational Duchenne programs as a horizontal product pipeline. Each row represents a drug or therapy with its sponsoring company and therapeutic approach, positioned by the most advanced clinical phase recorded in the catalog.
Columns run from Early Phase 1 through Phase 4. The filled bar shows how far each program has progressed. Programs are sorted with the most advanced developments at the top and Early Phase 1 programs at the bottom.
Observational studies and records labeled only as interventional are excluded so the chart focuses on interventional drug development phases. Click a program name to open its full trial page with eligibility, locations, and registry links.
Explore related views in Home, Active DMD Clinical Studies, and DMD Clinical Trial Statistics. The catalog was last updated August 26, 2026; the product pipeline changes when new trials are added or phases are revised.
